Frank

[Frank @FrankOftring]

@AmeliaBarty wispr flow probably doesn't care about price sensitive indie devs

consumers don't pay for productivity apps, enterprises do. and enterprises will continue to pay as long it leads to productivity improvements.

[Frank @FrankOftring]

@DavidSHolz @DanielleFong

[Frank @FrankOftring]

@PalmerLuckey You’re cooking

[Frank @FrankOftring]

@itsolelehmann Thats the dream! Easier said than done though

[Frank @FrankOftring]

@DanielLockyer Need to see the 30 day average strain scores of all the people complaining about whoop

[Frank @FrankOftring]

@likuev @mercury brother, we need a credit card

[Frank @FrankOftring]

@neetcode1 now that anyone can code, DSA interviews are even more important

[Frank @FrankOftring]

@getairchat might have just been too early. voice as input has become way more prominent with tools like wispr flow

i've essentially replaced all typing across ios/macos with dictation. even when posting

[Frank @FrankOftring]

@packyM X needs a slop button

[Frank @FrankOftring]

@arjunkhemani @naval I think your story is somewhat of an outlier case. The vast majority of young teens using social media are doomscrolling slop

[Frank @FrankOftring]

@packyM Banger from Nike

[Frank @FrankOftring]

People don’t know what they want until you ̶s̶h̶o̶w̶ ̶i̶t̶ ̶t̶o̶ ̶t̶h̶e̶m̶ ̶ give them a slider to figure it out for themselves

[Joanna Stern @JoannaStern]

There we go. Liquid Glass slider! Better late than never.

[Frank @FrankOftring]

I wish there was a way to know you’re the midwit before you’ve looped through the whole meme

[shirish @shiri_shh]

bro immigrated from Mexico and took a $28/hr contract welding job in 2015.

didn't even know what SpaceX was.

they gave him $10,000 in stock and let him buy more through payroll deductions.

that stake is now worth $880,000.

and he's one of 4,400 employees who became millionaires on Friday. welders. technicians. cafeteria staff.

[Derek Thompson @DKThomp]

This has quietly been a miracle month in medicine.

In the last 5 weeks we’ve got news on:

- retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels
- RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life
- small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol
- Mayo’s AI-assisted radiology showing vastly improved cancer detection
- this new therapy for metastatic solid tumors

This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.

[Frank @FrankOftring]

@signulll didn't realize you were an nba guy

[Frank @FrankOftring]

@packyM